SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C15 - Practical Training in Injection Techniques in the Treatment of Headache Disorders Skills Workshop

Event Time: Saturday April 22, 2017 1:00 pm to 3:00 pm
Topic(s): Headache, Pain and Palliative Care
Director(s): Morris Levin MD, FAAN
Description: This two-hour skills workshop will provide hands-on training in nerve blockade, including greater and lesser occipital nerves, supraorbital and supratrochlear nerves, and auriculotemporal nerves; posterior cervical trigger point injections with perhaps injection sites for TMD; and onabotulinum toxin injections using the FDA-approved protocol for chronic migraine.
Completion Message: Participants should be able to perform the key cranial nerve blocks used in the management of headache disorders, perform key trigger point injections used in the management of headache disorders, and perform onabotulinum toxin injections used in the treatment of chronic migraine.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Program Speakers - Tentative

Start/End Time Title Faculty
1:00 PM - 1:20 PM Introduction Morris Levin MD, FAAN 
1:20 PM - 2:50 PM Breakout Session A: Onabotulinum Toxin Injections Andrew Blumenfeld MD 
1:20 PM - 2:50 PM Breakout Session B: Nerve Blocks and Trigger Point Injections Morris Levin MD, FAAN, Matthew Robbins MD, FAAN 
1:20 PM - 2:50 PM Breakout Session A: Onabotulinum Toxin Injections Thomas Ward MD, FAAN 
2:50 PM - 3:00 PM Questions and Answers Faculty 

Disclosures

Speaker Disclosure
Andrew M. Blumenfeld, MD Dr. Blumenfeld has received personal compensation for activities with Allergan, Depomed, Alder, Lilly, Amgen, Avanir, Teva and Keller Labs as a speaker or consultant. Dr. Blumenfeld holds stock and/or stock options in Allergan, which sponsorred research in which Dr. Blumenfeld was involved as an investigator. Dr. Blumenfeld has received research support from Allergan.

Morris Levin, MD, FAAN Dr. Levin has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Amgen, Lilly, Supernus, Pernix.

Matthew S. Robbins, MD, FAAN Section Editor, Current Pain and Headache Reports, Springer. Site principal investigator for a clinical trial of sTMS by eNeura; funds directly to institution..

Thomas N. Ward, MD, FAAN Dr. Ward has received personal compensation for activities with Cowen and Co. as a consultant. Dr. Ward has received personal compensation in an editorial capacity from Headache: The Journal of Head and Face Pain and American Headache Society.

Register Now

Related Courses

Sunday April 22, 2018

3:30 PM-5:30 PM
C48 Low and High Pressure Headache: Clinical Presentation and Approach to Evaluation and Management Kathleen Digre MD, FAAN

Wednesday April 25, 2018

7:00 AM-9:00 AM
C136 Emergency and Inpatient Management of Migraine and Other Headache Disorders Stephanie Nahas MD, FAAN
C142 Evaluation and Treatment of Common Spine Disorders J. D. Bartleson MD, FAAN
3:30 PM-5:30 PM
N4 Neuroscience in the Clinic: Opioid Use and Abuse: The Overlapping Neurobiology of Pain and Addiction, and the Path Toward Better Treatments Jessica Robinson Papp MD, FAAN,
Walter Koroshetz MD, FAAN

Thursday April 26, 2018

1:00 PM-3:00 PM
C193 Practical Training in Injection Techniques in the Treatment of Headache Disorders Skills Workshop Morris Levin MD, FAAN
6:30 PM-9:30 PM
C213 Case Studies: Challenging Headache Cases Kathleen Digre MD, FAAN

MEMBER LOG IN

Forgot Password?